Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program

INTRODUCTION: The availability of the sodium-free potassium binder patiromer opens new opportunities for hyperkalemia management. OBJECTIVE: Our objective was to compare data from a 4-year global pharmacovigilance database of adverse events (AEs) reported in patients prescribed patiromer in clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossignol, Patrick, David, Lea, Chan, Christine, Conrad, Ansgar, Weir, Matthew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324724/
https://www.ncbi.nlm.nih.gov/pubmed/34018121
http://dx.doi.org/10.1007/s40801-021-00254-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324724/
https://www.ncbi.nlm.nih.gov/pubmed/34018121
http://dx.doi.org/10.1007/s40801-021-00254-7

Ejemplares similares